For example, in the case of Apoa2c transgenic mice that are AApoAII amyloidosis-susceptible, the plasma ApoA-II levels in homozygous transgenic mice were 1.57- or 1.26-fold greater than in wild-type or heterozygous littermates, respectively [14]. This evidence concerns the gene APOA2 and amyloidosis.